Context Therapeutics Inc. (CNTX)
NASDAQ: CNTX · Real-Time Price · USD
2.160
-0.170 (-7.30%)
May 15, 2026, 4:00 PM EDT - Market closed
Context Therapeutics Market Cap
Context Therapeutics has a market cap or net worth of $198.46 million as of May 18, 2026. Its market cap has increased by 156.51% in one year.
Market Cap
198.46M
Enterprise Value
144.21M
1-Year Change
156.51%
Ranking
Category
Stock Price
$2.16
Market Cap Chart
Since the IPO on October 20, 2021, Context Therapeutics's market cap has increased from $51.03M to $198.46M, an increase of 288.92%. That is a compound annual growth rate of 34.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 15, 2026 | 198.46M | 46.94% |
| Dec 31, 2025 | 135.06M | 43.39% |
| Dec 31, 2024 | 94.19M | 422.07% |
| Dec 29, 2023 | 18.04M | 73.39% |
| Dec 30, 2022 | 10.41M | -75.50% |
| Dec 31, 2021 | 42.46M | -16.78% |
| Oct 20, 2021 | 51.03M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Keros Therapeutics | 207.81M |
| Humacyte | 206.50M |
| Canton Strategic Holdings | 205.10M |
| Milestone Pharmaceuticals | 204.76M |
| Fate Therapeutics | 204.56M |
| Corbus Pharmaceuticals Holdings | 195.63M |
| Elicio Therapeutics | 195.55M |
| Innate Pharma | 189.73M |